Clinical and Prognostic Association of Transcription Factor SOX4 in Gastric Cancer

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Fang, Chia Lang ^a,b   Hseu, You Cheng ^c   Lin, Yi Feng ^d,e   Hung, Shih Ting ^e   Tai, Chein ^f   Uen, Yih Huei ^d,e,f   Lin, Kai Yuan ^e,g  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d Chi Mei Hospital Chiali   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

^f SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^g CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SOX4;

AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STOMACH CANCER; STOMACH CARCINOGENESIS; STUDENT T TEST; TWO TAILED TEST;

AGED; CELL LINE, TUMOR; CELL NUCLEUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RNA, MESSENGER; SOXC TRANSCRIPTION FACTORS; STOMACH NEOPLASMS;

EID: 84871438188     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052804     Document Type: Article

References (42)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, et al. (2009) Gastric cancer. Crit Rev Oncol Hematol 71: 127-164.
3. Kamangar F, Dores GM, Anderson WF, (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150.
4. Fuchs CS, Mayer RJ, (1995) Gastric carcinoma. N Engl J Med 333: 32-41.
5. Dicken BJ, Saunders LD, Jhangri GS, de Gara C, Cass C, et al. (2004) Gastric cancer: establishing predictors of biological behavior with use of population-based data. Ann Surg Oncol 11: 629-635.
6. Becker KF, Keller G, Hoefler H, (2000) The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 9: 5-11.
7. Lin KY, Fang CL, Chen Y, Li CF, Chen SH, et al. (2010) Overexpression of nuclear protein kinase CK2 ß subunit and prognosis in human gastric carcinoma. Ann Surg Oncol 17: 1695-1702.
8. Lin KY, Tai C, Hsu JC, Li CF, Fang CL, et al. (2011) Overexpression of nuclear protein kinase CK2 a catalytic subunit (CK2a) as a poor prognosticator in human colorectal cancer. PLoS ONE 6: e17193.
9. Lin KY, Wang LH, Hseu YC, Fang CL, Yang HL, et al. (2012) Clinical significance of increased guanine nucleotide exchange factor Vav3 expression in human gastric cancer. Molecular Cancer Res 10: 750-759.
10. Baba K, Ishigami S, Arigami T, Uenosono Y, Okumura H, et al. (2012) Mesothelin expression correlates with prolonged patient survival in gastric cancer. J Surg Oncol 105: 195-199.
11. Begnami MD, Fukuda E, Fregnani JH, Nonogaki S, Montagnini AL, et al. (2011) Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinoma: HER2 and HER3 are predictors of poor outcome. J Clin Oncol 29: 3030-3036.
12. Schepers GE, Teasdale RD, Koopman P, (2002) Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell 3: 167-170.
13. Wilson M, Koopman P, (2002) Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev 12: 441-446.
14. van de Wetering M, Oosterwegel M, van Norren K, Clevers H, (1993) Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J 12: 3847-3854.
15. Ya J, Schilham MW, de Boer PA, Moorman AF, Clevers H, et al. (1998) Sox4-deficiency syndrome in mice is an animal model for common trunk. Circ Res 83: 986-994.
16. Schilham MW, Oosterwegel MA, Moerer P, Ya J, de Boer PA, et al. (1996) Defects in cardiac outflow tract formation and pro-Blymphocyte expansion in mice lacking Sox-4. Nature 380: 711-714.
17. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, et al. (2002) New genes involved in cancer identified by retroviral tagging. Nat Genet 32: 166-174.
18. Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, et al. (2002) Genomewide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet 32: 160-165.
19. Shin MS, Fredrickson TN, Hartley JW, Suzuki T, Agaki K, et al. (2004) High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res 64: 4419-4427.
20. Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sørensen FB, Thykjaer T, et al. (2006) SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Research 66: 3434-3442.
21. Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, et al. (2006) Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Research 66: 4011-4019.
22. Andersen CL, Christensen LL, Thorsen K, Schepeler T, Sørensen FB, et al. (2009) Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. British Journal of Cancer 100: 511-523.
23. Medina PP, Castillo SD, Blanco S, Sanz-Garcia M, Largo C, et al. (2009) The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Human Molecular Genetics 18: 1343-1352.
24. Pramoonjago P, Baras AS, Moskaluk CA, (2006) Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells. Oncogene 25: 5626-5639.
25. Pan X, Zhao J, Zhang WN, Li HY, Mu R, et al. (2009) Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proceedings of the National Academy of Sciences of the United States of America 106: 3788-3793.
26. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-233.
27. de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, et al. (2008) Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro-Oncology 10: 648-660.
28. Lin KY, Fang CL, Uen YH, Chang CC, Lou HY, et al. (2008) Overexpression of protein kinase Ca mRNA may be an independent prognostic marker for gastric carcinoma. Journal of Surgical Oncology 97: 538-543.
29. Oliveira FJ, Ferrao H, Furtado E, Batista H, Conceicao L, (1998) Early gastric cancer: Report of 58 cases. Gastric Cancer 1: 51-6.
30. Hundahl SA, Phillips JL, Menck HR, (2000) The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 88: 921-32.
31. Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, et al. (2009) Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrail cancer. Cancer Res 69: 9038-9046.
32. Hur W, Rhim H, Jung CK, Kim JD, Bae SH, et al. (2010) SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis 31: 1298-1307.
33. Jafarnejad SM, Wani AA, Mertinka M, Li G, (2010) Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. Am J Pathol 177: 32741-32752.
34. Wang C, Zhao H, Lu J, Yin J, Zang L, et al. (2012) Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma. Diagn Pathol 7: 41.
35. Shen R, Pan S, Qi S, Lin X, Cheng S, (2010) Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem Biophys Res Commun 394: 1047-1052.
36. Ma L, Teruya-Feldstein J, Weinberg RA, (2007) Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
37. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
38. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, et al. (2008) The microRNAs miR-373 and miR-520c promote tumor invasion and metastasis. Nat Cell Biol 10: 202-210.
39. Eastham AM, Spencer H, Soncin F, Ritson S, Merry CL, et al. (2007) Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 67: 11254-11262.
40. Guarino M, (2007) Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 39: 2153-2160.
41. Voulgari A, Pintzas A, (2009) Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 1796: 5-90.
42. Zhang J, Liang Q, Lei Y, Yao M, Li L, et al. (2012) SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res 72: 4597-4608.